Business
InspireMD to Report First Quarter 2021 Financial Results on Tuesday, May 11, 2021 and Provide Corporate Update
Earnings conference call to be held Tuesday, May 11, 2021 at 8:30 a.m. ET TEL AVIV, Israel, May 04, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American:
About this update from Inspiremd Inc.
[{"type":"text","content":"Earnings conference call to be held Tuesday, May 11, 2021 at 8:30 a.m. ET\nTEL AVIV, Israel, May 04, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR) (“InspireMD” or the “Company”), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), today announces it will report fiscal first quarter 2021 financial results on Tuesday, May 11, 2021 before the market opens. Management will host a conference call on Tuesday, May 11, at 8:30 a.m. ET to review financial results and provide an update on corporate developments. Following management’s formal remarks, there will be a question-and-answer session. Participants are asked to pre-register for the call through the following link: https://dpregister.com/sreg/10155884/e7e882ac64. Please note that registered participants will receive their dial in number upon registration and will dial directly into the call without delay. Those without internet access or unable to pre-register may dial in by calling: 1-844-854-4417 (domestic), 1-412-317-5739 (international) or 1-80-9212373 (Israel). All callers should dial in approximately 10 minutes prior to the scheduled start time and ask to be joined into the InspireMD call. The conference call will also be available through a live webcast found here: https://services.choruscall.com/mediaframe/webcast.html?webcastid=yieueRnJ. Additionally, it will be broadcast live through the Company’s website via the following link: https://www.inspiremd.com/en/investors/investor-relations/. A webcast replay of the call will be available approximately one hour after the end of the call through August 11, 2021 at the above links. A telephonic replay of the call will be available through May 25, 2021 and may be accessed by calling 1-877-344-7529 (domestic) or 1-412-317-0088 (international) and using access code 10155884. About InspireMD, Inc.InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free, long-term outcomes. InspireMD’s common stock is quoted on the NYSE American under the ticker symbol NSPR and certain warrants are quoted on the NYSE American under the ticker symbol NSPR.WS and NSPR.WSB. Forward-looking Statements This press release contain...